Bloomfield Hills, Mich.-based CureLauncher, which matches people to all enrolling clinical trials, has announced an exclusive partnership with Treatment Diaries, a social but private network anonymously connecting individuals affected by similar illnesses through online health-related conversations captured in personal diaries.

Treatment Diaries members and visitors will be directed to the CureLauncher web site, where specially trained relationship managers help individuals find a clinical trial that may offer access to a new diagnostic test, treatment or rehabilitative approach.

“Partnering with CureLauncher compliments our mission,” said Amy Ohm, founder and CEO of Treatment Diaries. “We work to connect people to support them through the treatment experience, and CureLauncher helps find people new treatments matching their unique goals and conditions. It is this personalized support from each of our organizations that empowers people.”

Nearly 200 million Americans have a chronic disease such as diabetes, heart disease, asthma or cancer. Less than five percent of them know where to find new treatments available in clinical trials, according to the Center for Information & Study on Clinical Research Participation (CISCRP). Yet, some of America’s best medical care is available through these clinical trials.

"CureLauncher redefines the approach to clinical trials by putting people and their families first," said David Fuehrer, CureLauncher president, who is also a two-time cancer survivor and an active speaker and volunteer for various support communities.

“We are thrilled to work with Treatment Diaries,” said Fuehrer. “We want to become a part of this strong community support to help as many people as we can.”